The FDA granted Fast Track designation for treatments, and the company Oncolytics Biotech began using LinkedIn for its social media presence.
1 report, 1 independent
Updated Aug 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA granted Fast Track designation for treatments, and the company Oncolytics Biotech began using LinkedIn for its social media presence.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Oncolytics Biotech
Nothing else this week.
-
LinkedIn
American social networking website for people in professional occupations
Related events
- GE HealthCare announced on August 21, 2025, that it was using LinkedIn for company news, and Jennifer Fox serves as the media contact.
- FDA approval expands patient access to therapies for ACCORD.
- FDA is willing to review updated submissions, while biotech hubs leverage AI to ease clinical development bottlenecks.
- President of Boston University used LinkedIn to announce strategic initiatives on October 5, 2026.
- Sto uses LinkedIn for corporate communication.
Coverage
Newest first; wire copies grouped- CNW GroupOncolytics Biotech® Announces Upcoming Investor Conferences in September SAN DIEGO, Aug. 28, 2025 /CNW/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage im